Transdermal Electroacupuncture for Opioid Detoxification

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Opioid Dependency

In brief

This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opioids.

Key facts

Study ID

NCT00742170

Run by

Mclean Hospital

People needed

48

Starts

2007-08-01

Expected to finish

2010-01-01

Last updated by the study team

2014-10-21

Who can join

Age: 18 and older, up to 59. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current opioid dependence
• Current buprenorphine detoxification
• 18-59 years of age
• English proficiency

You may not qualify if…

• Acute mania, psychosis, or suicidality
• Cognitive impairments precluding informed consent
• Heart disease or contraindicated heart condition
• Use of pace maker
• History of seizure disorder
• Current detoxification from alcohol or benzodiazepines
• Inability to return to follow-up visits
• For women, pregnancy

Where it is running

• McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.